Driven by an increasing prevalence of diabetes, the total market for Insulin and Non-Insulin Antidiabetics is expected to reach sales worth US$ 2803 Million by 2015.
A new report from IMARC Group expects that as a result of an avalanche of patent expiries and a thin pipeline, sales worth US$ 8.7 Billion will be eroded from the US cholesterol market.
Most Dermatologists are concerned with Oral Minocycline side effects and will prefer prescribing their patients Topical Minocycline for Rosacea, Acne, Skin Infections and Chronic Wounds.
Driven by a strong growth in the sales of vaccines, the demand for efficient cold chain packaging and transportation services is expected to grow robustly in the coming years.
VBS announces the publication of a scientific article which describes the use of an experimental endoarterial biopsy catheter to describe the hemodynamic, angiographic, and histologic progression of an aortopulmonary shunt model of PAH.
A recently published paper from Vascular Biosciences (VBS) has been selected by the Faculty of 1000 (F1000) as one of the top 2 percent of all published articles in the biological and medical sciences in 2011.
Hetero launched today Kutub, a generic version of Dapoxetine, in India. Dapoxetine is the world's first and only drug in the pharmaceutical market for on-demand use in Premature Ejaculation (PE). The launch is considered a new beginning in the treatment of PE as Dapoxetine is a unique medicine (tablet), designed to be taken only when needed, that is 1-3 hours before anticipated intimate activity.
Chris Brogan, Social Media expert and NY Times bestseller, has just released a five part you tube video series ''5 tips in 5 minutes to deliver an effective social media campaign in pharma'.
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
ImpactRx measures the impact of promotion on physician prescribing behavior. Patients request more than 250,000 brand annually, ImpactRx then records physician's treatment behavior in response to their request.
RHT Consulting and Hult students have conducted a leaders and laggards analysis on top-ranked pharmaceutical companies based on business model innovation, operational model innovation and product/service innovation.
New Haven, CT June 22nd, 2011: CMDBioscience announced today that they will exhibit at the 22nd American Peptide Symposium in San Diego, CA. The company will introduce CMDInventusSM, their proprietary computational discovery platform aimed at discovering novel peptide candidates.
AdvantaPure now offers ten ways to identify hoses used in pharmaceutical and other critical process applications. Identification helps increase hose connection accuracy. Options include various uses of colors, printing directly on the hose, protected labels, laser-etched metal components, and electronic methods.
Axium Healthcare Pharmacy, one of the nation's largest independent specialty pharmacy providers, announced today the addition of VictrelisTM and IncivekTM to its HEPVisionsSM Therapy Management Program.
Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course of August.
ImpactRx expanded its psychiatry research panel to better serve the growing neruoscience category, in particular ADD/ADHD market. Psychiatrists are evaluating and reporting prescribing behavior. iPhone-connected psychiatrists capture feedback in real time.
VBS Pharmaceuticals announces the publication of a peer-reviewed scientific article that describes a novel peptide that specifically targets and penetrates the vasculature of lungs affected by pulmonary arterial hypertension (PAH) in the current issue of the American Journal of Pathology.
Dr. Rebecca Baillie, will present a webinar in Rosa's monthly public webinar series "How to build a PhysioPD model" on June 20, 2011 at 1:00 pm EDT (GMT -5:00).
CMDBioscience, a computational biotechnology company focused on developing computational tools to enable peptide discovery announced today the release of CMDInventus, a proprietary and fully validated computational peptide discovery platform. This platform when combined with the CMD expertise is poised to revolutionize the field of novel peptide discovery.
PharmTech Inc., Libertyville, IL, has recently published the results of their annual survey of pharmaceutical industry decision makers "Serialization & Traceability 2011: Where are you now?".
Satisfied Users & 
Approved Press Releases
